Li P - Search Results

1

Immunogenicity and safety of Southern Hemisphere inactivated quadrivalent influenza vaccine: a Phase III, open-label study of adults in Brazil.

Zerbini CA, Ribeiro Dos Santos R, Jose Nunes M, Soni J, Li P, Jain VK, Ofori-Anyinam O. Zerbini CA, et al. Among authors: li p. Braz J Infect Dis. 2017 Jan-Feb;21(1):63-70. doi: 10.1016/j.bjid.2016.10.003. Epub 2016 Nov 29. Braz J Infect Dis. 2017. PMID: 27912069 Free PMC article. Clinical Trial.

2

Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1/2 trial in adults.

Langley JM, Frenette L, Ferguson L, Riff D, Sheldon E, Risi G, Johnson C, Li P, Kenney R, Innis B, Fries L. Langley JM, et al. Among authors: li p. J Infect Dis. 2010 Jun 1;201(11):1644-53. doi: 10.1086/652701. J Infect Dis. 2010. PMID: 20423222 Clinical Trial.

3

Dose-sparing H5N1 A/Indonesia/05/2005 pre-pandemic influenza vaccine in adults and elderly adults: a phase III, placebo-controlled, randomized study.

Langley JM, Risi G, Caldwell M, Gilderman L, Berwald B, Fogarty C, Poling T, Riff D, Baron M, Frenette L, Sheldon E, Collins H, Shepard M, Dionne M, Brune D, Ferguson L, Vaughn D, Li P, Fries L. Langley JM, et al. Among authors: li p. J Infect Dis. 2011 Jun 15;203(12):1729-38. doi: 10.1093/infdis/jir172. J Infect Dis. 2011. PMID: 21606531 Free PMC article. Clinical Trial.

4

Safety and long-term humoral immune response in adults after vaccination with an H1N1 2009 pandemic influenza vaccine with or without AS03 adjuvant.

Ferguson M, Risi G, Davis M, Sheldon E, Baron M, Li P, Madariaga M, Fries L, Godeaux O, Vaughn D. Ferguson M, et al. Among authors: li p. J Infect Dis. 2012 Mar 1;205(5):733-44. doi: 10.1093/infdis/jir641. J Infect Dis. 2012. PMID: 22315336 Clinical Trial.

5

An observer-blind, randomized, multi-center trial assessing long-term safety and immunogenicity of AS03-adjuvanted or unadjuvanted H1N1/2009 influenza vaccines in children 10-17 years of age.

Poder A, Simurka P, Li P, Roy-Ghanta S, Vaughn D. Poder A, et al. Among authors: li p. Vaccine. 2014 Feb 19;32(9):1121-9. doi: 10.1016/j.vaccine.2013.11.031. Epub 2013 Nov 16. Vaccine. 2014. PMID: 24252703 Free article. Clinical Trial.

6

A historically-controlled Phase III study in adults to characterize the acceptability of a process change for manufacturing inactivated quadrivalent influenza vaccine.

Jain VK, Chandrasekaran V, Wang L, Li P, Liu A, Innis BL. Jain VK, et al. Among authors: li p. BMC Infect Dis. 2014 Mar 10;14:133. doi: 10.1186/1471-2334-14-133. BMC Infect Dis. 2014. PMID: 24606983 Free PMC article. Clinical Trial.

7

Relative efficacy of AS03-adjuvanted pandemic influenza A(H1N1) vaccine in children: results of a controlled, randomized efficacy trial.

Nolan T, Roy-Ghanta S, Montellano M, Weckx L, Ulloa-Gutierrez R, Lazcano-Ponce E, Kerdpanich A, Safadi MA, Cruz-Valdez A, Litao S, Lim FS, de Los Santos AM, Weber MA, Tinoco JC, Mezerville MH, Faingezicht I, Kosuwon P, Lopez P, Borja-Tabora C, Li P, Durviaux S, Fries L, Dubin G, Breuer T, Innis BL, Vaughn DW. Nolan T, et al. Among authors: li p. J Infect Dis. 2014 Aug 15;210(4):545-57. doi: 10.1093/infdis/jiu173. Epub 2014 Mar 20. J Infect Dis. 2014. PMID: 24652494 Free PMC article. Clinical Trial.

8

Responses to A(H1N1)pdm09 influenza vaccines in participants previously vaccinated with seasonal influenza vaccine: a randomized, observer-blind, controlled study.

Roy-Ghanta S, Van der Most R, Li P, Vaughn DW. Roy-Ghanta S, et al. Among authors: li p. J Infect Dis. 2014 Nov 1;210(9):1419-30. doi: 10.1093/infdis/jiu284. Epub 2014 May 26. J Infect Dis. 2014. PMID: 24864125 Free PMC article. Clinical Trial.

9

Immunogenicity and safety of AS03A-adjuvanted H5N1 influenza vaccine prepared from bulk antigen after stockpiling for 4 years.

Godeaux O, Izurieta P, Madariaga M, Dramé M, Li P, Vaughn DW. Godeaux O, et al. Among authors: li p. Vaccine. 2015 Apr 27;33(18):2189-95. doi: 10.1016/j.vaccine.2014.07.062. Epub 2014 Jul 30. Vaccine. 2015. PMID: 25090645 Free article. Clinical Trial.

10

Safety of AS03-adjuvanted inactivated split virion A(H1N1)pdm09 and H5N1 influenza virus vaccines administered to adults: pooled analysis of 28 clinical trials.

Vaughn DW, Seifert H, Hepburn A, Dewe W, Li P, Drame M, Cohet C, Innis BL, Fries LF. Vaughn DW, et al. Among authors: li p. Hum Vaccin Immunother. 2014;10(10):2942-57. doi: 10.4161/21645515.2014.972149. Epub 2014 Nov 21. Hum Vaccin Immunother. 2014. PMID: 25483467 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

33,858 results

Search Page